首页> 外文会议>International Conference on Miniaturized Systems for Chemistry and Life Sciences >POINT-MUTATION DETECTION OF MITOCHONDRIAL DNA BY USING MICROFLUIDIC SYSTEMS
【24h】

POINT-MUTATION DETECTION OF MITOCHONDRIAL DNA BY USING MICROFLUIDIC SYSTEMS

机译:用微流体系统点突变检测线粒体DNA

获取原文

摘要

Mitochondrial disorders are a group of complex and heterogeneous diseases that may be caused by molecular defects in mitochondrial genomes. Pathogenic mitochondrial DNA (mtDNA) mutations are usually present in the heteroplasmic form. The degree of mtDNA mutation heteroplasmy varies among different tissues. Thus, it is important to detect and quantify the degree of mutation heteroplasmy of mtDNA. Currently, more than 100 pathogenic mtDNA point-mutations have been documented and new ones are still being extensively explored. Among them, A3243G mutation, which causes the myopathy encephalopathy lactic acidosis and stroke (MELAS) syndrome and diabetes, attracts considerable interest recently. In this study, a new microfluidic system capable of point-mutation detection of mtDNA has been demonstrated. The entire process including cell lysis, enzyme digestion, amplification of target fragment of mtDNA and optical detection can be automatically performed. Experimental results showed that the point-mutation of mtDNA can be successfully detected.
机译:线粒体疾病是一组复杂和异质疾病,其可能是线粒体基因组中的分子缺陷引起的。致病线粒体DNA(MTDNA)突变通常以异质形式存在。 MTDNA突变异质度的程度在不同的组织中变化。因此,重要的是要检测和量化MTDNA的突变度异质程度。目前,已经记录了超过100名致病性MTDNA点突变,并且仍然广泛探索新的致病性MTDNA点突变。其中,A3243G突变导致肌病脑病乳酸中毒和中风(MELAS)综合征和糖尿病,最近吸引了相当大的利益。在该研究中,已经证明了能够点突变检测MTDNA的新微流体系统。可以自动自动地执行包括细胞裂解,酶消化,靶片段的酶消化,靶片段的扩增和光学检测的整个过程。实验结果表明,可以成功检测MTDNA的点突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号